Tamoxifen prolongs survival and alleviates symptoms in mice with fatal X-linked myotubular myopathy
X-linked myotubular myopathy (XLMTM) is a severe muscle disease with no effective treatment. Here, the authors show that tamoxifen, a drug used to treat breast cancer, rescues the pathology in a mouse model of the disease, at least in part by normalizing expression of the disease modifier proteins D...
Saved in:
Main Authors: | Elinam Gayi, Laurence A. Neff, Xènia Massana Muñoz, Hesham M. Ismail, Marta Sierra, Thomas Mercier, Laurent A. Décosterd, Jocelyn Laporte, Belinda S. Cowling, Olivier M. Dorchies, Leonardo Scapozza |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/55e31f0f62ce4d928b4e2b13a82b1d60 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances
by: Raquel Gómez-Oca, et al.
Published: (2021) -
Tamoxifen therapy in a murine model of myotubular myopathy
by: Nika Maani, et al.
Published: (2018) -
Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice
by: Hichem Tasfaout, et al.
Published: (2017) -
Integrative data mining highlights candidate genes for monogenic myopathies.
by: Osorio Abath Neto, et al.
Published: (2014) -
Atrial Myopathy Underlying Atrial Fibrillation
by: Harold Rivner, et al.
Published: (2020)